Company intelligence / Profile preview
Ipca Laboratories Limited
- Ownership
- Private
- Employees
- ~12000
- Development stage
- Phase 1
Overview
Ipca Laboratories is a fully integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 APIs across various therapeutic segments. The company has received approvals from major regulatory authorities including US-FDA, UK-MHRA, South Africa-MCC, Brazil-ANVISA, and Australia-TGA.
- Therapeutic areas
- CardiovascularRheumatologyImmunologyOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculesAPIs (Active Pharmaceutical Ingredients)formulationsbiosimilars
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Ipca Laboratories Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ipca Laboratories Limited.